Results 231 to 240 of about 6,410,919 (241)

Effects of an inhibitor of topoisomerase II, ICRF-193 on the formation of ultraviolet-induced chromosomal aberrations

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1998
T Ikushima
exaly  

Hydroxylated 2,4-diphenyl indenopyridine derivatives as a selective non-intercalative topoisomerase IIα catalytic inhibitor

European Journal of Medicinal Chemistry, 2015
Eung-Seok Lee, Youngjoo Kwon, Til Bahadur Thapa Magar   +2 more
exaly  

The anticancer multi-kinase inhibitor dovitinib also targets topoisomerase I and topoisomerase II

Biochemical Pharmacology, 2012
Jack Yalowich, John L. Nitiss, Brian B Hasinoff   +2 more
exaly  

Effects of camptothecin, a topoisomerase I inhibitor, on

Biochemical Pharmacology, 1998
Theresa Shapiro, Jared N Cumming, T A Shapiro   +2 more
exaly  

Chemoenzymatic synthesis of deoxy analogues of the DNA topoisomerase II inhibitor eleutherin and the 3C-protease inhibitor thysanone

Tetrahedron, 2008
Jonathan Sperry, Margaret Brimble
exaly  

Design, synthesis, topoisomerase I & II inhibitory activity, antiproliferative activity, and structure–activity relationship study of pyrazoline derivatives: An ATP-competitive human topoisomerase IIα catalytic inhibitor

Bioorganic and Medicinal Chemistry, 2016
Youngjoo Kwon, Adnan Kadı, Hatem A Abdel-Aziz   +2 more
exaly  

Purification of GidA protein, a novel topoisomerase II inhibitor produced by Streptomyces flavoviridis

World Journal of Microbiology and Biotechnology, 2013
Muthusamy Palaniswamy, J Angayarkanni
exaly  

Etoposide: four decades of development of a topoisomerase II inhibitor

European Journal of Cancer, 1998
K R Hande
exaly  

Abnormal chromosome migration and chromosome aberrations in mouse oocytes during meiosis II in the presence of topoisomerase II inhibitor ICRF-193

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 2002
Hiroyuki Tateno
exaly  

Chemotherapy with Irinotecan (CPT-11), a Topoisomerase-I Inhibitor, for Refractory and Relapsed Non-Hodgkin's Lymphoma

Leukemia and Lymphoma, 2001
exaly